Filing Overview
Registrant: Ikena Oncology, Inc. The request metadata identifies Imagenebio, Inc., but the filing names Ikena Oncology, Inc.
Form 8-K date: June 7, 2024; filed June 10, 2024. The report covers the company’s Annual Meeting of Stockholders held June 7, 2024.
Business and Reporting Context
The filing reports voting results under Item 5.07. As of the April 10, 2024 record date, 41,889,525 shares of common stock were outstanding.
Key Financial Metrics and Capital Structure
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating or financial metrics.
Material Corporate Actions
- Stockholders elected Owen Hughes and Mark Manfredi, Ph.D. as Class III directors for terms expiring at the 2027 annual meeting, subject to earlier departure.
- Owen Hughes received 22,250,184 votes for, 4,967,774 withheld, and 7,247,349 broker non-votes.
- Mark Manfredi, Ph.D. received 24,738,833 votes for, 2,479,125 withheld, and 7,247,349 broker non-votes.
- Stockholders ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
- The auditor ratification vote was 34,421,661 for, 31,819 against, 11,827 abstentions, and no broker non-votes.
- No other matters were submitted to or voted on at the meeting.
Outlook, Risks, and Unusual Items
The filing provides no management guidance, business outlook, material risk update, contingency disclosure, or unusual financial item. The principal disclosed matters are director elections and auditor ratification.
Investor Verification Items
- Verify the company identity because the supplied metadata names Imagenebio, Inc., while the filing names Ikena Oncology, Inc.
- Review the April 26, 2024 definitive proxy statement for detailed proposal, governance, and director information.
- Confirm the final board composition and director terms following the annual meeting.
- Review subsequent filings for financial condition, liquidity, financing activity, and operating outlook, none of which are addressed in this 8-K.